About Gastroenterologisch-Hepatologisches Zentrum Kiel
Clinical Trials at Gastroenterologisch-Hepatologisches Zentrum Kiel
During the past decade, Gastroenterologisch-Hepatologisches Zentrum Kiel conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Gastroenterologisch-Hepatologisches Zentrum Kiel
According to Clinical.Site data, the most researched conditions in "Gastroenterologisch-Hepatologisches Zentrum Kiel" are
"Hepatitis C, Chronic" (2 trials), "Liver Fibrosis Due to NASH" (2 trials), "Nonalcoholic Steatohepatitis" (2 trials), "Compensated Cirrhosis" (1 trials) and "Hepatitis B, Chronic" (1 trials). Many other conditions were trialed in "Gastroenterologisch-Hepatologisches Zentrum Kiel" in a lesser frequency.
Clinical Trials Intervention Types at Gastroenterologisch-Hepatologisches Zentrum Kiel
Most popular intervention types in "Gastroenterologisch-Hepatologisches Zentrum Kiel" are "Drug" (6 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "SIM" (2 trials), "Cilofexor" (1 trials), "GS-5885" (1 trials) and "GS-9451" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Gastroenterologisch-Hepatologisches Zentrum Kiel
The vast majority of trials in "Gastroenterologisch-Hepatologisches Zentrum Kiel" are
11 trials for "All" genders.
Clinical Trials Status at Gastroenterologisch-Hepatologisches Zentrum Kiel
Currently, there are NaN active trials in "Gastroenterologisch-Hepatologisches Zentrum Kiel".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Gastroenterologisch-Hepatologisches Zentrum Kiel,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Gastroenterologisch-Hepatologisches Zentrum Kiel, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".